RhumbLine Advisers’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $755K | Buy |
58,091
+6,515
| +13% | +$84.7K | ﹤0.01% | 2392 |
|
|
2025
Q1 | $1.3M | Buy |
51,576
+3,103
| +6% | +$78.4K | ﹤0.01% | 2049 |
|
|
2024
Q4 | $1.67M | Buy |
48,473
+1,663
| +4% | +$57.2K | ﹤0.01% | 1983 |
|
|
2024
Q3 | $2.31M | Sell |
46,810
-655
| -1% | -$32.4K | ﹤0.01% | 1824 |
|
|
2024
Q2 | $2.86M | Buy |
47,465
+8,632
| +22% | +$519K | ﹤0.01% | 1699 |
|
|
2024
Q1 | $2M | Buy |
38,833
+1,275
| +3% | +$65.8K | ﹤0.01% | 1914 |
|
|
2023
Q4 | $1.51M | Buy |
37,558
+1,728
| +5% | +$69.7K | ﹤0.01% | 2050 |
|
|
2023
Q3 | $999K | Buy |
35,830
+1,148
| +3% | +$32K | ﹤0.01% | 2213 |
|
|
2023
Q2 | $999K | Buy |
34,682
+3,967
| +13% | +$114K | ﹤0.01% | 2289 |
|
|
2023
Q1 | $512K | Buy |
30,715
+4,795
| +18% | +$79.9K | ﹤0.01% | 2425 |
|
|
2022
Q4 | $328K | Buy |
25,920
+567
| +2% | +$7.18K | ﹤0.01% | 2644 |
|
|
2022
Q3 | $304K | Buy |
25,353
+1,688
| +7% | +$20.2K | ﹤0.01% | 2723 |
|
|
2022
Q2 | $333K | Buy |
23,665
+11,312
| +92% | +$159K | ﹤0.01% | 2706 |
|
|
2022
Q1 | $153K | Buy |
+12,353
| New | +$153K | ﹤0.01% | 2814 |
|